The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126586471 12658647 1 I 20160601 20160810 20160817 20160817 EXP FR-SA-2016SA148715 AVENTIS 0.00 T M Y 0.00000 20160817 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126586471 12658647 1 SS CORTANCYL PREDNISONE 1 Oral UNK 0 2 MG/KG QD
126586471 12658647 2 SS LASILIX FUROSEMIDE 1 Oral UNK 0 40 MG QD
126586471 12658647 3 PS CEFOTAXIME CEFOTAXIME SODIUM 1 Intravenous (not otherwise specified) U UNK 62659 33 MG/KG
126586471 12658647 4 SS TAVANIC LEVOFLOXACIN 1 Unknown U UNK 0
126586471 12658647 5 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) TAKEN TO^2016 UNK 0 1 MG/KG
126586471 12658647 6 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) TAKEN TO^2016 UNK 0 35 MG BID
126586471 12658647 7 SS KETAMINE KETAMINE 1 Intravenous (not otherwise specified) UNK 0
126586471 12658647 8 SS CELOCURINE SUCCINYLCHOLINE CHLORIDE 1 Intravenous (not otherwise specified) UNK 0
126586471 12658647 9 SS NIMBEX CISATRACURIUM BESYLATE 1 Intravenous (not otherwise specified) UNK 0
126586471 12658647 10 SS SALBUTAMOL ALBUTEROL 1 Intravenous (not otherwise specified) U UNK 0 1.8 UG QD
126586471 12658647 11 SS SALBUTAMOL ALBUTEROL 1 Respiratory (inhalation) U UNK 0 5 UG /hr
126586471 12658647 12 SS ATROVENT IPRATROPIUM BROMIDE 1 Respiratory (inhalation) U UNK 0 .25 MG Q3H
126586471 12658647 13 SS LOXEN NICARDIPINE HYDROCHLORIDE 1 Oral U UNK 0
126586471 12658647 14 SS CIFLOX CIPROFLOXACIN 1 Intravenous (not otherwise specified) U UNK 0
126586471 12658647 15 SS MAGNESIUM SULFATE. MAGNESIUM SULFATE 1 Intravenous (not otherwise specified) Y UNK 0 50 MG/KG QD
126586471 12658647 16 C VENTOLINE ALBUTEROL 1 0

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
126586471 12658647 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126586471 12658647 Altered state of consciousness
126586471 12658647 Cerebrovascular accident
126586471 12658647 Cerebrovascular disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126586471 12658647 1 20160526 20160526 0
126586471 12658647 2 20160526 20160526 0
126586471 12658647 3 20160527 0
126586471 12658647 4 20160527 0
126586471 12658647 5 20160527 0
126586471 12658647 6 2016 0
126586471 12658647 7 20160527 20160531 0
126586471 12658647 8 20160527 20160527 0
126586471 12658647 9 20160527 20160531 0
126586471 12658647 10 20160527 20160530 0
126586471 12658647 11 20160527 0
126586471 12658647 12 20160527 0
126586471 12658647 13 20160531 0
126586471 12658647 14 20160531 0
126586471 12658647 15 20160527 0